Upgrade to SI Premium - Free Trial

Boston Scientific (BSX) Top Rating Maintained at Needham & Company Despite Mixed Qtr

October 24, 2018 12:52 PM
Needham & Company analyst Mike Matson reiterated a Strong Buy and $43 price target on Boston Scientific (NYSE: BSX) as ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View

Next Articles